✦ LIBER ✦

Combined silencing of K-ras and Akt2 oncogenes achieves synergistic effects in inhibiting pancreatic cancer cell growth in vitro and in vivo

✍ Scribed by Shi, X H; Liang, Z Y; Ren, X Y; Liu, T H

Book ID: 109842589
Publisher: Nature Publishing Group
Year: 2008
Tongue: English
Weight: 403 KB
Volume: 16
Category: Article
ISSN: 0929-1903
DOI: 10.1038/cgt.2008.82

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

RNA interference-mediated silencing of U

RNA interference-mediated silencing of UBCH10 gene inhibits colorectal cancer cell growth in vitro and in vivo

✍ Shi-Min Chen; Chun-Ying Jiang; Jian-Ying Wu; Bin Liu; Ying-Jian Chen; Cheng-Jin 📂 Article 📅 2010 🏛 John Wiley and Sons 🌐 English ⚖ 420 KB

Synergistic growth inhibition in HL-60 c

Synergistic growth inhibition in HL-60 cells by the combination of acyclic retinoid and vitamin K2

✍ Junichi Kitagawa; Takeshi Hara; Hisashi Tsurumi; Soranobu Ninomiya; Kengo Ogawa; 📂 Article 📅 2010 🏛 Springer-Verlag 🌐 English ⚖ 457 KB

Inhibition of cervical cancer cell growt

Inhibition of cervical cancer cell growth in vitro and in vivo with lentiviral-vector delivered short hairpin RNA targeting human papillomavirus E6 and E7 oncogenes

✍ Gu, W; Putral, L; Hengst, K; Minto, K; Saunders, N A; Leggatt, G; McMillan, N A 📂 Article 📅 2006 🏛 Nature Publishing Group 🌐 English ⚖ 430 KB

Grb2-SH3 ligand inhibits the growth of H

Grb2-SH3 ligand inhibits the growth of HER2+ cancer cells and has antitumor effects in human cancer xenografts alone and in combination with docetaxel

✍ Brunilde Gril; Michel Vidal; Franck Assayag; Marie-France Poupon; Wang-Qing Liu; 📂 Article 📅 2007 🏛 John Wiley and Sons 🌐 French ⚖ 633 KB

## Abstract HER2 represents an important signaling pathway in breast and other cancers. Herceptin has demonstrated clinical activity, but resistance is common. Thus, new therapeutic approaches to the HER2 pathway are needed. Grb2 is an adaptor protein involved in Ras‐dependent signaling induced by

Recombinant antibody toxins specific for

Recombinant antibody toxins specific for ErbB2 and EGF receptor inhibit the in vitro growth of human head and neck cancer cells and cause rapid tumor regression in vivo

✍ Marc Azemar; Mathias Schmidt; Friederike Arlt; Pierre Kennel; Burkhard Brandt; A 📂 Article 📅 2000 🏛 John Wiley and Sons 🌐 French ⚖ 130 KB 👁 2 views

## Overexpression of the ErbB2 and epidermal growth factor receptor (EGFR) tyrosine kinases is frequently observed in squamous cell carcinomas of the head and neck, and has been correlated with shorter overall survival. By immunoblot analysis, we have found EGFR and ErbB2 expression in 6 out of 6 e

Opposite effects of nanocrystalline full

Opposite effects of nanocrystalline fullerene (C60) on tumour cell growth in vitro and in vivo and a possible role of immunosupression in the cancer-promoting activity of C60

✍ Nevena S. Zogovic; Nadezda S. Nikolic; Sanja D. Vranjes-Djuric; Ljubica M. Harha 📂 Article 📅 2009 🏛 Elsevier Science 🌐 English ⚖ 851 KB

In the present study, we compared the effects of nanocrystalline fullerene suspension (nanoC 60 ) on tumour cell growth in vitro and in vivo. NanoC 60 suspension was prepared by solvent exchange using tetrahydrofuran to dissolve C 60 . In vitro, nanoC 60 caused oxidative stress, mitochondrial depola